Tareq Abadl: Polychromasia as a Morphologic Indicator of Bone Marrow Response
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
“Polychromasia — When the Bone Marrow Says: ‘I’m Trying’
Sometimes, those bluish red cells on a peripheral smear are more than just a color change… they’re a message from the marrow.
What is Polychromasia?
Polychromasia refers to red blood cells (RBCs) that appear larger and bluish-gray on a peripheral blood smear.
This happens because these cells still contain residual RNA, making them less mature than normal RBCs.
In simple terms:
Polychromasia is a visible sign of immature RBCs in circulation.
And it often correlates with reticulocytosis.
Why Does It Matter?
Because it tells you something critical: The bone marrow is actively responding.
When you see polychromasia, ask yourself:
Is the body trying to compensate for anemia?
Clinical Significance
Polychromasia is commonly seen in conditions where RBC destruction or loss is increased, such as:
- Hemolytic anemia
- Acute or chronic blood loss
- Warm autoimmune hemolytic anemia (WAHA)
According to the American Society of Hematology (ASH) Image Bank, polychromasia is a hallmark feature in WAHA, reflecting increased marrow activity to replace destroyed red cells.
Why the Peripheral Smear Still Matters?
Even in advanced lab settings, the smear remains powerful:
A simple color change in RBCs can shift your thinking from:
‘Just low hemoglobin’ to ‘Is there hemolysis? Blood loss? Marrow response?’
Don’t Forget the Reticulocyte Count!
Always correlate smear findings with: Reticulocyte count
Because together they answer: Is the marrow responding appropriately or not?
Bottom Line
Polychromasia is not just a morphology finding…
It’s a functional clue that the marrow is working hard to restore balance.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation